Pharmaceutical company AstraZeneca will use Cognizant’s collaboration platform to increase productivity and reduce costs as part of a business process service agreement.
Cognizant will manage clinical data in support of AstraZeneca's product development programme.
AstraZeneca will use Cognizant's proprietary platform, Cognizant 2.0, which uses Web 2.0 technology. This will enable AstraZeneca to share information globally and make it easier to carry out clinical studies across various countries. A total of 80,000 Cognizant staff are connected through the platform
“Leveraging Cognizant’s IT and business process expertise allows AstraZeneca to focus more time, energy and investment on clinical activities that will make a difference in developing innovative medicines more quickly for patients,” said Karin Wingstrand, vice-president and head of clinical development at AstraZeneca.
The combination of IT and BPO, as well as domain expertise from a single supplier, is an attractive proposition for companies looking to streamline operations.
IT and BPO suppliers will increasingly consolidate as customers look for a single source of services, according to Peter Brudenal, lawyer at Lawrence Graham. He said many large service providers will attempt to become more like Accenture.